Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-27 @ 10:54 PM
Study NCT ID:
NCT06353360
Status:
RECRUITING
Last Update Posted:
2024-08-09
First Post:
2024-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.
Sponsor:
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-19
First Submit QC Date:
None
Study First Post Date:
2024-04-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-06
Last Update Post Date:
2024-08-09
Last Update Post Date Type:
ACTUAL